Cargando…
Progresses in Fluorescence Imaging Guidance for Bone and Soft Tissue Sarcoma Surgery
R0 surgical resection is the preferred treatment for bone and soft tissue sarcoma. However, there is still a lack of precise technology that can visualize bone and soft tissue sarcoma during surgery to assist the surgeon in judging the tumor surgical boundary. Fluorescence imaging technology has bee...
Autores principales: | Chen, Zhenyi, Huang, Huayi, He, Siyuan, Wang, Yi, Cai, Lin, Xie, Yuanlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289289/ https://www.ncbi.nlm.nih.gov/pubmed/35860548 http://dx.doi.org/10.3389/fonc.2022.879697 |
Ejemplares similares
-
Application of Indocyanine Green Fluorescence Imaging in Assisting Biopsy of Musculoskeletal Tumors
por: He, Siyuan, et al.
Publicado: (2023) -
Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma
por: Li, Shenglong
Publicado: (2021) -
New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023) -
Nanomaterial Technology and Soft Tissue Sarcomas
por: Zhou, Changkai, et al.
Publicado: (2022) -
Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas
por: Zhang, Qing, et al.
Publicado: (2023)